Cited 8 time in
Stereochemical Determination of Fistularins Isolated from the Marine Sponge Ecionemia acervus and Their Regulatory Effect on Intestinal Inflammation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ji, Yeong Kwang | - |
| dc.contributor.author | Lee, Seon Min | - |
| dc.contributor.author | Kim, Na-Hyun | - |
| dc.contributor.author | Nguyen Van Tu | - |
| dc.contributor.author | Kim, Yun Na | - |
| dc.contributor.author | Heo, Jeong Doo | - |
| dc.contributor.author | Jeong, Eun Ju | - |
| dc.contributor.author | Rho, Jung-Rae | - |
| dc.date.accessioned | 2022-12-26T10:45:23Z | - |
| dc.date.available | 2022-12-26T10:45:23Z | - |
| dc.date.issued | 2021-03 | - |
| dc.identifier.issn | 1660-3397 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/4052 | - |
| dc.description.abstract | By activity-guided fractionation based on inhibition of nitric oxide (NO) and prostaglandin E2 (PGE(2)), six fistularin compounds (1-6) were isolated from the marine sponge Ecionemia acervus (order Astrophorida). Based on stereochemical structure determination using Mosher's method, fistularin-3 was assigned as a new stereoisomer. On the basis of the stereochemistry of fistularin-3, the stereochemical homogeneity of all six compounds was established by comparing carbon and proton chemical shifts. For fistularin-1 (1) and -2 (2), quantum calculations were performed to confirm their stereochemistry. In a co-culture system of human epithelial Caco-2 cells and THP-1 macrophages, all six isolated compounds showed potent anti-inflammatory activities. These bioactive fistularins inhibited the production of NO, PGE(2), TNF-alpha, IL-1 beta, and IL-6 induced by lipopolysaccharide and interferon gamma. Inducible NO synthase and cyclooxygenase-2 expression and MAPK phosphorylation were downregulated in response to the inhibition of NF-kappa B nuclear translocation. Among the compounds tested, fistularin-1 (1) and 19-deoxyfistularin-3 (4) showed the highest activity. These findings suggest the potential use of the marine sponge E. acervus and its metabolites as pharmaceuticals for the treatment of inflammation-related diseases including inflammatory bowel disease. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
| dc.title | Stereochemical Determination of Fistularins Isolated from the Marine Sponge Ecionemia acervus and Their Regulatory Effect on Intestinal Inflammation | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/md19030170 | - |
| dc.identifier.scopusid | 2-s2.0-85103862278 | - |
| dc.identifier.wosid | 000633827500001 | - |
| dc.identifier.bibliographicCitation | Marine Drugs, v.19, no.3 | - |
| dc.citation.title | Marine Drugs | - |
| dc.citation.volume | 19 | - |
| dc.citation.number | 3 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordAuthor | fistularin | - |
| dc.subject.keywordAuthor | bromotyrosine alkaloid | - |
| dc.subject.keywordAuthor | Ecionmeia acervus | - |
| dc.subject.keywordAuthor | inflammatory bowel disease | - |
| dc.subject.keywordAuthor | co-culture | - |
| dc.subject.keywordAuthor | Mosher&#8217 | - |
| dc.subject.keywordAuthor | s ester | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
